Lois Chandler
Chief Operating Officer presso GENE BIOTHERAPEUTICS, INC.
Profilo
Lois A.
Chandler is currently the Chief Operating Officer at Taxus Cardium Pharmaceuticals Group, Inc. She previously worked as the Vice President-Product Development at Activation Therapeutics, Inc. from 2006 to 2019.
Dr. Chandler completed her undergraduate degree at Stanford University and holds a doctorate from the University of Southern California.
Posizioni attive di Lois Chandler
| Società | Posizione | Inizio |
|---|---|---|
| GENE BIOTHERAPEUTICS, INC. | Chief Operating Officer | 01/07/2019 |
Precedenti posizioni note di Lois Chandler
| Società | Posizione | Fine |
|---|---|---|
Activation Therapeutics, Inc.
 Activation Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Part of Taxus Cardium Pharmaceuticals Group, Inc., Activation Therapeutics, Inc. develops late-stage clinical and commercial development of regenerative medicine therapeutics. | Corporate Officer/Principal | 01/01/2019 |
Formazione di Lois Chandler
| Stanford University | Undergraduate Degree |
| University of Southern California | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GENE BIOTHERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Activation Therapeutics, Inc.
Activation Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Part of Taxus Cardium Pharmaceuticals Group, Inc., Activation Therapeutics, Inc. develops late-stage clinical and commercial development of regenerative medicine therapeutics. | Health Technology |
- Borsa valori
- Insiders
- Lois Chandler
